Candesartan vs Osimertinib

Candesartan vs Osimertinib: Overview

This comparison examines the pharmacological differences between Candesartan and Osimertinib.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Osimertinib — C28H33N7O2.

Molecular Weight: Candesartan — 610.6640 g/mol; Osimertinib — 499.6050 g/mol.

Type: Candesartan — Small molecule; Osimertinib — Small molecule.